Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Elsevier apology

Elsevier, a publisher of scientific, technical, and medical information, has issued a public apology after it became apparent that the Australian offices published several sham journals on behalf of pharmaceutical companies.

The Australasian Journal of Bone and Joint Medicine was apparently peer-reviewed but is unavailable via MEDLINE and does not appear to have a website. The publication appears to have been sponsored by Merck and was used as a marketing tool for drugs such as Fosamax® and Vioxx®.

Elsevier are currently conducting an internal review and have reviewed current practices to ensure this does not happen again. It is currently believed that this is an isolated incident.

Action: Clinicians should ensure that changes in practice are supported by best evidence published in trusted sources such as NICE, Cochrane and the National Prescribing Centre.

Share 'Elsevier apology' on Email Share 'Elsevier apology' on Delicious Share 'Elsevier apology' on Digg Share 'Elsevier apology' on Facebook Share 'Elsevier apology' on Google+ Share 'Elsevier apology' on reddit Share 'Elsevier apology' on StumbleUpon Share 'Elsevier apology' on Twitter

atomic-wealth

No Comments to “Elsevier apology”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,527 spam comments.

atomic-wealth
fond-illness
summer